FDA inspection

Sever Pharma Solutions: FDA inspection ending Mar 31, 2023

FDA inspection 1204531 · No Action Indicated (NAI) · Malmo

Key facts

Inspection ID 1204531
Firm Sever Pharma Solutions
FEI number 3004620701
Address Agnselundsvagen 27
City Malmo
Country Sweden
Fiscal year 2023
Inspection end date Mar 31, 2023
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections